Publications from 1999–2003

1. Bakardjiev A, Azimi PH, Ascher D, Ashouri N, Janner D, Schuster F, Visvesvara G, Glaser C. Amebic Encephalitis Caused by Balamuthia mandrillaris: Report of Four Cases. Pediatr Infect Dis J 2003; 22(5): 447-453.
2. Schuster FL, Dunnebacke TH, Booton GC, Yagi S, Kohlmeier CK, Glaser C, Vugia D, Bakardjiev A, Azimi P, Maddux-Gonzalez M, Martinez AJ, Visvesvara GS. Environmental Isolation of Balamuthia mandrillaris Associated with a Case of Amebic Encephalitis. J Clin Microbiol 2003; 41(7): 3175-3180
3. Deville JG, Adler S, Azimi PH, Jantausch B, Morfin MR, Beltran S, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss J. Linezolid Versus Vancomycin in the Treatment of Known or Suspected Resistant Gram-positive Infections in Neonates. Pediatr Infect Dis J 2003; 22(9): S158-S163.
   
4. Azimi PH: Spirochetal infections, Syphillis, Nonvenerial Syphilitic Disease, and Leptospirosis, Nelso Textbook of Pediatrics, 17th Edition 2002.
   
5. Staat MA, Azimi PH, Berke T, Roberts N, Bernstein DI, Ward RL, Pickering LK, Matson DO. Clinical presentations of rotavirus infection among hospitalized children. Pediatr Infect Dis J 2002; 21: 221-7.
   
6. Lin FC, Azimi PH, et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal Group B streptococcal disease. Am J Obstet Gynecol 2001; 184: 1204-1210.
   
7. Lin FC, Phillips JB, Azimi PH, et al. Level of maternal antibody required to protect neonates against early-onset disease caused by Group B streptococcus type Ia: a multicenter, seroepidemiology study. J of ID 2001; 184: 1022-8.
   
8. Kaplan SL, Patterson L, Edwards K, Azimi PH. Linezolid for the treatment of community-acquired pneumonia in hospitalized children. Pediatr Infect Dis J 2001; 20: 488-94.
   
9. Lin FC, Azimi PH, et al. Antibiotic susceptibility profiles of Group B streptococci isolated from neonates. Clin ID 2000; 31: 76.
   
10. Azimi PH, Barson WJ, Janner D, et al. Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. J of ID 1999; 18: 609-613.